Pfizer Inc (PFE) stock

PFENYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3046% above fair value

$29.45+0.09 (+0.31%)

Close on Nov 11, 2026Market cap $167.86BP/E 42.1Yield 5.84%

Pfizer EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Pfizer's EV/EBITDA was 16.5× on Nov 10, 2026, against 10.6× a year earlier. Over the last 5 years it ranged from 5.8× to 41.8×, with a median of 10.8×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 10, 2026	16.5×	+6.2
2025	Dec 31, 2025	10.4×	−4.9
2024	Dec 31, 2024	15.3×	+4.5
2023	Dec 29, 2023	10.8×	+1.4
2014	Apr 30, 2014	9.4×	−0.3
2013	Dec 31, 2013	9.7×	−0.7
2012	Dec 31, 2012	10.3×	+1.7
2011	Dec 30, 2011	8.6×	−0.2
2010	Dec 31, 2010	8.8×	+1.8
2009	Dec 31, 2009	7.0×	–